BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24857366)

  • 1. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
    Pinkus JL; Amato AA; Taylor JP; Greenberg SA
    Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy.
    Li S; Zhang P; Freibaum BD; Kim NC; Kolaitis RM; Molliex A; Kanagaraj AP; Yabe I; Tanino M; Tanaka S; Sasaki H; Ross ED; Taylor JP; Kim HJ
    Hum Mol Genet; 2016 Mar; 25(5):936-50. PubMed ID: 26744327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
    Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
    Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
    Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
    Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
    Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.
    Fifita JA; Zhang KY; Galper J; Williams KL; McCann EP; Hogan AL; Saunders N; Bauer D; Tarr IS; Pamphlett R; Nicholson GA; Rowe D; Yang S; Blair IP
    Neurodegener Dis; 2017; 17(6):304-312. PubMed ID: 29131108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
    Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
    Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
    Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.
    Salajegheh M; Pinkus JL; Taylor JP; Amato AA; Nazareno R; Baloh RH; Greenberg SA
    Muscle Nerve; 2009 Jul; 40(1):19-31. PubMed ID: 19533646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
    Cortese A; Plagnol V; Brady S; Simone R; Lashley T; Acevedo-Arozena A; de Silva R; Greensmith L; Holton J; Hanna MG; Fisher EM; Fratta P
    Neurobiol Aging; 2014 Jun; 35(6):1491-8. PubMed ID: 24462217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
    Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
    Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with "multisystem proteinopathy" and frontotemporal lobar degeneration phenotypes.
    Le Ber I; Van Bortel I; Nicolas G; Bouya-Ahmed K; Camuzat A; Wallon D; De Septenville A; Latouche M; Lattante S; Kabashi E; Jornea L; Hannequin D; Brice A;
    Neurobiol Aging; 2014 Apr; 35(4):934.e5-6. PubMed ID: 24119545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
    Salajegheh M; Pinkus JL; Nazareno R; Amato AA; Parker KC; Greenberg SA
    Muscle Nerve; 2009 Oct; 40(4):520-8. PubMed ID: 19626672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
    Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC
    Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
    Kim JH; Hahm B; Kim YK; Choi M; Jang SK
    J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation.
    Ford LP; Wright WE; Shay JW
    Oncogene; 2002 Jan; 21(4):580-3. PubMed ID: 11850782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.
    Weihl CC; Pestronk A
    Curr Opin Neurol; 2010 Oct; 23(5):482-8. PubMed ID: 20664349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β signaling is upregulated in sporadic inclusion body myositis.
    Noda S; Koike H; Maeshima S; Nakanishi H; Iijima M; Matsuo K; Kimura S; Katsuno M; Sobue G
    Muscle Nerve; 2017 May; 55(5):741-747. PubMed ID: 27623743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.